WO1999004828A3 - Use of hyaluronic acid derivatives in the preparation of biomaterials - Google Patents

Use of hyaluronic acid derivatives in the preparation of biomaterials Download PDF

Info

Publication number
WO1999004828A3
WO1999004828A3 PCT/EP1998/004716 EP9804716W WO9904828A3 WO 1999004828 A3 WO1999004828 A3 WO 1999004828A3 EP 9804716 W EP9804716 W EP 9804716W WO 9904828 A3 WO9904828 A3 WO 9904828A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
biomaterials
hyaluronic acid
acid derivatives
formation
Prior art date
Application number
PCT/EP1998/004716
Other languages
French (fr)
Other versions
WO1999004828A2 (en
Inventor
Alberto Rivarossa
Daniele Pressato
Original Assignee
Fidia Advanced Biopolymers Srl
Alberto Rivarossa
Daniele Pressato
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AU92555/98A priority Critical patent/AU749627B2/en
Priority to JP2000503879A priority patent/JP4417547B2/en
Priority to CA002298733A priority patent/CA2298733C/en
Priority to AT98945104T priority patent/ATE311208T1/en
Priority to DE69832616T priority patent/DE69832616T2/en
Priority to EP98945104A priority patent/EP0999859B1/en
Application filed by Fidia Advanced Biopolymers Srl, Alberto Rivarossa, Daniele Pressato filed Critical Fidia Advanced Biopolymers Srl
Priority to IL13414098A priority patent/IL134140A0/en
Publication of WO1999004828A2 publication Critical patent/WO1999004828A2/en
Publication of WO1999004828A3 publication Critical patent/WO1999004828A3/en
Priority to IL134140A priority patent/IL134140A/en
Priority to HK00107189A priority patent/HK1028210A1/en
Priority to US10/139,878 priority patent/US7202230B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/041—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Abstract

The present invention describes the use of polysaccharide derivatives for the preparation of biocompatible and biodegradable biomaterials with absorbent properties for body fluids and physical haemostatic activity, to be used in both venous and arterial vascular anastomoses and to prevent the formation of post-surgical adherence of the vessels with the surrounding tissues scar formation.
PCT/EP1998/004716 1997-07-28 1998-07-28 Use of hyaluronic acid derivatives in the preparation of biomaterials WO1999004828A2 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP2000503879A JP4417547B2 (en) 1997-07-28 1998-07-28 Use of hyaluronic acid derivatives in the manufacture of biocompatible materials having physical hemostatic and embolic activity and prophylactic activity for adhesion formation after anastomosis
CA002298733A CA2298733C (en) 1997-07-28 1998-07-28 Hyaluronic acid derivatives for the preparation of haemostatic biomaterials for use following anastomosis
AT98945104T ATE311208T1 (en) 1997-07-28 1998-07-28 USE OF HYALUONIC ACID DERIVATIVES FOR PRODUCING BIOMATERIAL
DE69832616T DE69832616T2 (en) 1997-07-28 1998-07-28 USE OF HYALUONIC ACID DERIVATIVES FOR THE MANUFACTURE OF BIOMATERIAL
EP98945104A EP0999859B1 (en) 1997-07-28 1998-07-28 Use of hyaluronic acid derivatives in the preparation of biomaterials
AU92555/98A AU749627B2 (en) 1997-07-28 1998-07-28 Use of hyaluronic acid derivatives in the preparation of biomaterials with a physical haemostatic and plugging activity and a preventive activity in the formation of adhesions following anastomosis
IL13414098A IL134140A0 (en) 1997-07-28 1998-07-28 Use of hyaluronic acid derivatives in the preparation of biomaterials with a physical haemostatic and plugging activity and a preventive activity in the formation of adhesion following anastomosis
IL134140A IL134140A (en) 1997-07-28 2000-01-20 Use of hyaluronic acid derivatives in the preparation of biomaterials with a physical haemostatic and plugging activity and a preventive activity in the formation of adhesions following anastomosis
HK00107189A HK1028210A1 (en) 1997-07-28 2000-11-10 Use of hyaluronic acid derivatives in the preparation of biomaterials
US10/139,878 US7202230B2 (en) 1997-07-28 2002-05-07 Use of hyaluronic acid derivatives in the preparation of biomaterials with a physical haemostatic and plugging activity

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITPD97A000170 1997-07-28
IT97PD000170A IT1294797B1 (en) 1997-07-28 1997-07-28 USE OF HYALURONIC ACID DERIVATIVES IN THE PREPARATION OF BIOMATERIALS WITH PHYSICAL AND BUFFERING HEMOSTATIC ACTIVITIES

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US49394300A Continuation-In-Part 1997-07-28 2000-01-28

Publications (2)

Publication Number Publication Date
WO1999004828A2 WO1999004828A2 (en) 1999-02-04
WO1999004828A3 true WO1999004828A3 (en) 1999-06-10

Family

ID=11391877

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/004716 WO1999004828A2 (en) 1997-07-28 1998-07-28 Use of hyaluronic acid derivatives in the preparation of biomaterials

Country Status (13)

Country Link
US (1) US7202230B2 (en)
EP (1) EP0999859B1 (en)
JP (1) JP4417547B2 (en)
AT (1) ATE311208T1 (en)
AU (1) AU749627B2 (en)
CA (1) CA2298733C (en)
DE (1) DE69832616T2 (en)
DK (1) DK0999859T3 (en)
ES (1) ES2253827T3 (en)
HK (1) HK1028210A1 (en)
IL (2) IL134140A0 (en)
IT (1) IT1294797B1 (en)
WO (1) WO1999004828A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9265858B2 (en) 2012-06-12 2016-02-23 Ferrosan Medical Devices A/S Dry haemostatic composition
US9533069B2 (en) 2008-02-29 2017-01-03 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1306679B1 (en) * 1999-06-29 2001-10-02 Fidia Advanced Biopolymers Srl USE OF HYALURONIC ACID DERIVATIVES FOR THE PREPARATION OF PHARMACEUTICAL AND BIOMATERIAL COMPOSITIONS FOR THE PREVENTION OF
WO2001097826A2 (en) * 2000-06-16 2001-12-27 University Of Medicine And Dentistry Of New Jersey Hemostatic compositions, devices and methods
US7094428B2 (en) 2000-06-16 2006-08-22 The University Of Medicine And Dentistry Of New Jersey Hemostatic compositions, devices and methods
US6235796B1 (en) * 2000-06-26 2001-05-22 Sarfaraz K. Niazi Use of fluorocarbons for the prevention of surgical adhesions
JP4500263B2 (en) * 2003-07-28 2010-07-14 帝人株式会社 Temperature-responsive hydrogel
DE10349722A1 (en) * 2003-10-23 2005-06-16 Beschorner, Katharina, Dr. Composition for arthritis / arthritis treatment, in particular of joints
WO2006005340A1 (en) * 2004-07-09 2006-01-19 Ferrosan A/S Haemostatic composition comprising hyaluronic acid
ITPD20040245A1 (en) * 2004-10-08 2005-01-08 Fidia Advanced Biopolymers Srl BIOMATERIALS MADE UP OF HYALURONIC ACID, SULFATE AND GELL, USABLE IN THE PREVENTION OF SPINAL ADHESIONS
ES2313445T3 (en) * 2004-12-14 2009-03-01 Fidia Advanced Biopolymers S.R.L. PROCEDURE FOR THE PREPARATION OF BI- AND THREE-DIMENSIONAL POLYMER ARMS.
ITPD20040312A1 (en) * 2004-12-15 2005-03-15 Fidia Advanced Biopolymers Srl PROSTHESIS AND SUPPORT FOR REPLACEMENT, REPAIR, REGENERATION OF THE MENISCUS
ITPD20050206A1 (en) 2005-07-07 2007-01-08 Fidia Advanced Biopolymers Srl BIOMATERIALS IN THE FORM OF FIBER TO BE USED AS MEDICAL DEVICES IN THE TREATMENT OF WOUNDS AND THEIR PROCESSES OF PRODUCTION
ITMI20051415A1 (en) * 2005-07-22 2007-01-23 Fidia Advanced Biopolymers Srl BIOMATERIALS BASED ON SALT-MADE CORBOSSIMETHYLCELLULOSE WITH ZINC ASSOCIATED WITH IALURONIC ACID DERIVATIVES TO BE USED AS MEDICAL DEVICES WITH ANTIMICROBIAL AND ANTIFUNGAL ACTIVITY AND THEIR PRODUCTION PROCESS
WO2007103993A2 (en) * 2006-03-07 2007-09-13 Axle International Bioactive scaffold for therapeutic and adhesion prevention applications
ITPD20060219A1 (en) 2006-05-31 2007-12-01 Fidia Farmaceutici PHARMACEUTICAL COMPOSITIONS CONTAINING HYALURONIC ACID SULFATED IN THE TREATMENT OF OSTEOARTHROSIS
US8343942B2 (en) 2008-04-04 2013-01-01 University Of Utah Research Foundation Methods for treating interstitial cystitis
AU2009231634B2 (en) 2008-04-04 2014-05-15 University Of Utah Research Foundation Alkylated semi-synthetic glycosaminoglycosan ethers, and methods for making and using thereof
ES2829971T3 (en) * 2008-09-02 2021-06-02 Tautona Group Lp Hyaluronic acid threads and / or derivatives thereof, methods to manufacture them and uses thereof
TWI458833B (en) 2010-05-11 2014-11-01 Univ China Medical Nanometal dispersion and method for preparing the same
CA2830933A1 (en) 2011-03-23 2012-09-27 University Of Utah Research Foundation Methods for treating or preventing urological inflammation
EP2822474B1 (en) 2012-03-06 2018-05-02 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
EP3010419B1 (en) 2013-06-21 2020-05-20 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
AU2014361291B2 (en) 2013-12-11 2017-11-30 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
PT3226905T (en) * 2014-02-27 2022-01-19 Synartro Ab Hyaluronan conjugates with pharmaceutically active substances, methods and compositions
JP6726852B2 (en) 2014-10-13 2020-07-22 フェッローサン メディカル ディバイス エー／エス Dry composition for use in hemostasis and wound healing
JP6747650B2 (en) 2014-12-24 2020-08-26 フェロサン メディカル デバイシーズ エイ／エス Syringe for holding and mixing the first substance and the second substance
JP6747651B2 (en) 2015-07-03 2020-08-26 フェロサン メディカル デバイシーズ エイ／エス Syringe for holding vacuum in storage and for mixing two components
KR20180027126A (en) * 2016-09-06 2018-03-14 (주)한국비엠아이 Hemostatic Composition comprising cross-linked hyaluronic acid derivative matrix
US11337994B2 (en) 2016-09-15 2022-05-24 University Of Utah Research Foundation In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
EP4321182A2 (en) 2018-05-09 2024-02-14 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition
KR101980063B1 (en) * 2019-01-25 2019-05-17 주식회사 휴메딕스 Sponge Type Biodegradable Hemostatic Compositions Containing Hyaluronic Acid
CN113754795B (en) * 2021-10-19 2023-03-10 澳门大学 Sulfonated hyaluronic acid compound, preparation method and application thereof

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0216453A2 (en) * 1985-07-08 1987-04-01 FIDIA S.p.A. Esters of hyaluronic acid and their salts.
EP0341745A1 (en) * 1988-05-13 1989-11-15 FIDIA S.p.A. Crosslinked carboxy polysaccharides
WO1990014110A1 (en) * 1989-05-16 1990-11-29 Jean Vilain Improvements in or relating to pharmaceutical preparations
WO1992019802A1 (en) * 1991-05-01 1992-11-12 C.V. Laboratories Limited Alginate fabric, its use in wound dressings and surgical haemostats and a process for its manufacture
WO1995025751A1 (en) * 1994-03-23 1995-09-28 Fidia Advanced Biopolymers Srl Novel heparin-like sulfated polysaccharides
WO1996035720A1 (en) * 1995-05-10 1996-11-14 Fidia Advanced Biopolymers S.R.L. Heavy metal salts of succinic acid hemiesters with hyaluronic acid, or hyaluronic acid esters, a process for their preparation, and relative pharmaceutical compositions
WO1997002845A1 (en) * 1995-07-13 1997-01-30 Bristol-Myers Squibb Company A film for topical use in the treatment of wounds
WO1997007833A2 (en) * 1995-08-29 1997-03-06 Fidia Advanced Biopolymers, S.R.L. Biomaterials for preventing post-surgical adhesions comprised of hyaluronic acid derivatives

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202431A (en) 1985-07-08 1993-04-13 Fidia, S.P.A. Partial esters of hyaluronic acid
IT1203814B (en) 1986-06-30 1989-02-23 Fidia Farmaceutici ESTERS OF ALGINIC ACID
IT1198449B (en) 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani ESTERS OF POLYVALENT ALCOHOLS OF HYALURONIC ACID
US6174999B1 (en) * 1987-09-18 2001-01-16 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
IT1247157B (en) 1991-02-11 1994-12-12 Fidia Spa BIODEGRADABLE AND BIOABSORBABLE GUIDE CHANNELS TO BE USED FOR NERVE REGENERATION.
DE69210879T2 (en) 1991-02-11 1996-10-17 Fidia Spa Gellanester
IT1247472B (en) 1991-05-31 1994-12-17 Fidia Spa PROCESS FOR THE PREPARATION OF MICROSPHERES CONTAINING BIOLOGICALLY ACTIVE COMPONENTS.
IT1254704B (en) 1991-12-18 1995-10-09 Mini Ricerca Scient Tecnolog NON-WOVEN FABRIC ESSENTIALLY CONSTITUTED FROM DERIVATIVES OF HYALURONIC ACID
IT1264322B (en) 1992-07-30 1996-09-23 Lanfranco Callegaro SELF-CROSS-LINKED GELLANO ESTERS, PREPARATION PROCEDURE AND THEIR PHARMACEUTICAL AND BIOMEDICAL-SANITARY APPLICATIONS
IT1259141B (en) 1992-08-03 1996-03-11 Fidia Spa BIODEGRADABLE AND BIORIABSORBABLE GUIDE CHANNELS TO BE USED FOR TISSUE REPAIR AS ADJUVANT IN SURGICAL INTERVENTIONS
FR2723847A1 (en) * 1994-08-29 1996-03-01 Debiopharm Sa HEPARIN - BASED ANTITHROMBOTIC AND NON - HEMORRHAGIC COMPOSITIONS, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC APPLICATIONS.
IT1282994B1 (en) * 1996-05-10 1998-04-03 Inalco Spa DERIVATIVES OF THE POLYSACCHARIDE K5 HAVING HIGH ANTI-COAGULANT ACTIVITY
IT1287698B1 (en) 1996-08-29 1998-08-18 Fidia Advanced Biopolymers Srl SUTURE THREADS ESSENTIALLY MADE OF ESTERE DERIVATIVES OF HYALURONIC ACID

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0216453A2 (en) * 1985-07-08 1987-04-01 FIDIA S.p.A. Esters of hyaluronic acid and their salts.
EP0341745A1 (en) * 1988-05-13 1989-11-15 FIDIA S.p.A. Crosslinked carboxy polysaccharides
WO1990014110A1 (en) * 1989-05-16 1990-11-29 Jean Vilain Improvements in or relating to pharmaceutical preparations
WO1992019802A1 (en) * 1991-05-01 1992-11-12 C.V. Laboratories Limited Alginate fabric, its use in wound dressings and surgical haemostats and a process for its manufacture
WO1995025751A1 (en) * 1994-03-23 1995-09-28 Fidia Advanced Biopolymers Srl Novel heparin-like sulfated polysaccharides
WO1996035720A1 (en) * 1995-05-10 1996-11-14 Fidia Advanced Biopolymers S.R.L. Heavy metal salts of succinic acid hemiesters with hyaluronic acid, or hyaluronic acid esters, a process for their preparation, and relative pharmaceutical compositions
WO1997002845A1 (en) * 1995-07-13 1997-01-30 Bristol-Myers Squibb Company A film for topical use in the treatment of wounds
WO1997007833A2 (en) * 1995-08-29 1997-03-06 Fidia Advanced Biopolymers, S.R.L. Biomaterials for preventing post-surgical adhesions comprised of hyaluronic acid derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9533069B2 (en) 2008-02-29 2017-01-03 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US9265858B2 (en) 2012-06-12 2016-02-23 Ferrosan Medical Devices A/S Dry haemostatic composition

Also Published As

Publication number Publication date
JP2001510713A (en) 2001-08-07
DE69832616T2 (en) 2006-08-17
AU749627B2 (en) 2002-06-27
JP4417547B2 (en) 2010-02-17
ATE311208T1 (en) 2005-12-15
CA2298733C (en) 2009-09-01
DK0999859T3 (en) 2006-03-27
DE69832616D1 (en) 2006-01-05
US7202230B2 (en) 2007-04-10
EP0999859A2 (en) 2000-05-17
HK1028210A1 (en) 2001-02-09
IT1294797B1 (en) 1999-04-15
CA2298733A1 (en) 1999-02-04
US20030060448A1 (en) 2003-03-27
IL134140A0 (en) 2001-04-30
EP0999859B1 (en) 2005-11-30
AU9255598A (en) 1999-02-16
IL134140A (en) 2006-08-20
ITPD970170A1 (en) 1999-01-28
ES2253827T3 (en) 2006-06-01
WO1999004828A2 (en) 1999-02-04

Similar Documents

Publication Publication Date Title
WO1999004828A3 (en) Use of hyaluronic acid derivatives in the preparation of biomaterials
HK1047404A1 (en) Vascular coating composition
DK0418339T3 (en) Preparation and Method for Preventing Tissues Between Body Tissues
EP0956869A3 (en) Tissue sealant
CA2377483A1 (en) Graft-catheter vascular access system
CA2467797A1 (en) Increased biocompatibility of implantable medical devices
WO1999038544A3 (en) Calcification-resistant medical articles
WO2005112821A3 (en) Enhanced biological fixation of grafts
AU7441998A (en) Vascular prosthesis
AU2002231175A1 (en) Controlled release of anti-arrhythmic agents from a biodegradable polyethylene oxide hydrogel for local application to the heart
ZA943514B (en) The use of dihydrolipoic acid as an ophthalmological agent and to suppress intolerance reactions in the area between implants and living body tissue
NZ290218A (en) Composition to reduce adhesion in wound healing
DE59609340D1 (en) COATING FOR BIOMATERIAL TO BE INSERTED INTO THE BLOOD FLOW OR TISSUE OF THE HUMAN BODY
WO2001066037A3 (en) Intraluminal prosthesis
RU97102350A (en) ANTI-ADHESION AGENT
IL137988A0 (en) Sulphated hyaluronic acid and sulphated derivatives thereof covalently bound to polyurethanes, and the process for their preparation
TR199801365T2 (en) �yile�me s�recinin kontrol�.
AU4124089A (en) Use of ACE-inhibitor for suppressing the formation of neointima and the reduction of the vascular lumen by vascular wall thickening after vascular damage
WO2001035997A3 (en) Use of low-dose pdt to inhibit restenosis
AU7296600A (en) Use of a low molecular weight sulphated polysaccharide to obtain a medicine with antithrombotic activity
Li et al. Peptide‐coated vascular grafts: an in vivo study in sheep
CN208259808U (en) A kind of peripheral vein intravascular stent
SI0980251T1 (en) Tissue factor for influencing blood vessel formation
WO2004037120A3 (en) Implantable medical devices using zinc
UA30548A (en) Method for applying proximal anastomosis in autovenous bypassing in blood vessels of hip and shin

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 134140

Country of ref document: IL

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 92555/98

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2298733

Country of ref document: CA

Ref country code: CA

Ref document number: 2298733

Kind code of ref document: A

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: KR

WWE Wipo information: entry into national phase

Ref document number: PA/a/2000/001044

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1998945104

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1998945104

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 92555/98

Country of ref document: AU

WWG Wipo information: grant in national office

Ref document number: 1998945104

Country of ref document: EP